Bone-specific master transcription factor  Runx2 regulates signaling and metabolism related  programs in osteoprogenitors by Teplyuk, N.M. & Teplyuk, V.I.
Bone-specific master transcription factor 
Runx2 regulates signaling and metabolism related 
programs in osteoprogenitors
N. M. Teplyuk1, 2, V. I. Teplyuk2
1University of Massachusetts Medical School
55, Lake Ave North, 01655, Worcester, MA, USA
2Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine
150, Zabolotnogo str., Kiev, Ukraine, 03680
Nadiya.teplyuk@umassmed.edu
Aim. Runx2 (AML3) transcription factor is the key regulator of osteoblastic lineage progression and is
indispensable for the formation of mineral bones. Runx2 expression increases during differentiation of
osteoblasts to induce osteoblast-specific genes necessary for the production and deposition of bone mineral
matrix. However, Runx2 is also expressed at a lower level in early osteoprogenitors, where its function is
less understood. Here we study how Runx2 determines the early stages of osteoblastic commitment using the 
model system of Runx2 re-introduction in mouse calvaria cells with Runx2 null background. Method.
Affymetrix analysis, Western blot analysis and quantitative real-time reverse transcriptase PCR (qRT-PCR) 
analysis were employed.   Results. Gene expression profiling by Affymetrix microarrays revealed that along
with the induction of extracellular matrix and bone mineral deposition related phenotypic markers, Runx2
regulates several cell programs related to signaling and metabolism in the early osteoprogenitors.
Particularly, Runx2 regulates transcription of genes involved in G-protein coupled signaling network, FGF
and BMP/TGF beta signaling pathways and in biogenesis and metabolism pathways of steroid hormones.
Conclusion. The data indicate that the lineage specific program, regulated by the master regulatory
transcription factor, includes the regulation of cellular signaling and metabolism which may allow the
committed cell to react and behave differently in the same microenvironment.
Keywords: osteoblast progenitors, Runx2, signaling.
Introduction. Bone development, repair and remode-
ling homeostasis require constant differentiation of
mesenchymal stem cells through osteoprogenitors to
mature osteoblasts and osteocytes. Consistent with the
recent discoveries that a cell fate can be programmed
by only few master transcriptional regulators, the cell
fate along osteoblastic lineage is regulated by Runx2
and Osterix factors, both indispensable for bone for-
mation [1, 2]. 
Runx2 factor regulates expression of multiple tar-
get genes via direct activation and repression of genes
transcription or by epigenetic remodeling of gene regu- 
latory sequences [3].
Multiple Runx2 target genes are responsible for bo-
ne mineral production at the late stages of osteoblasts
maturation. However, Runx2 expression starts very
early along osteoblastic lineage, and its role at the early
steps of osteogenic commitment is scarcely understo-
od. This research is focused on the fundamental me-
chanisms of osteoprogenitors programming by Runx2.
We have compared the transcriptomes of Runx2 null
osteoprogenitor cells before and after their reconsti-
tution with wild type Runx2 protein or its non-func-
tional mutant using Affymetrix microarrays. We have
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found that several clusters of functionally related genes 
respond to Runx2 re-introduction. They include the
genes related to the osteoblast-specific signaling net-
work, hormones biosynthesis and general metabolism.
These genes define osteoblast cell identity in the bone
microenvironment.
Materials and methods. Cell culture and adeno-
virus infections. Runx2 null calvaria osteoprogenitors
cell line was developed previously from the fetal cal-
varial region of Runx2 knock-out mice by stable inte-
gration of Tert [4]. Runx2 null cells were maintained in 
αMEM supplemented with 10 % fetal bovine serum
(FBS) («Atlanta Biologicals», USA), 30 mM penicil-
lin-streptîmycin and 100 mM L-glutamine at 37 °C and 
5 % CO2 humidified atmosphere. Adenoviral vectors
containing cDNAs of full length Runx2 and its C-
terminal deletion mutants 1–361 (∆C) were each
transferred into the AdenoVatorTM expression construct 
(«Qbiogene», USA) from the corresponding pcDNA
expression vectors described previously.
Cells were plated for infections in 6-well plates
(12.5⋅104 cells/well). After 24 h, cells were infected
with 100 MOI of each virus in 600 µl of αMEM media
complemented with 1 % FBS for 4 h. Upon addition of
400 µl media containing 1 % FBS, cells were incubated
for additional 10 h.
Affymetrix analysis. Total RNA for Affymetrix
analysis (and subsequent qRT-PCR validation) was
isolated with Trizol reagent and purified using the
RNeasy Mini Kit («Qiagen», USA).  Analysis of gene
expression using Mouse Genome 430 2.0 Array was
performed as described earlier [5]. Data processing and 
sample comparisons were performed using an open
source library for statistical analysis (BioConductor
library for R environment; http://www.bioconductor.
org). Following Robust Multi-array Average expres-
sion measurement (RMA) and background correction,
the array values were subjected to quantile normaliza-
tion assuming identical signal distributions in each of
the arrays. Statistically significant differences between
probe sets were evaluated using Student’s T test (p <
< 0.05). Functional annotation of Affymetrix probe sets 
and gene ontology relationships between groups of co-
regulated genes were assessed using the Database for
Annotation, Visualization and Integrated Discovery
(DAVID 2.0) (http://david.abcc.ncifcrf.gov) [6].
Western blot analysis. Cell lysates were prepared
from cell pellets that were boiled in 100 µl of Direct
Lysis buffer (50 mM Tris-HCl, pH 6.8, 2 % SDS, 10 %
Glycerol, 12 % Urea, 25 µM MG132, 100 mM DTT
and 1 × Complete protease inhibitors) («Roche», USA). 
Aliquots of each lysate (5 µl) were separated in 10 %
sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis (PAGE). Proteins were transferred
using semi-wet blotting to nitrocellulose membranes
(«Millipore», USA). Phosphatase buffered saline
(PBS) with 5 % non-fat milk was used for 1 h at room
temperature to block non-specific protein binding.
Primary and secondary antibodies were used at 1:2,000 
dilutions for 1 h room temperature in PBS/0.1 %
Tween (PBST) with 1 % milk. Signal was detected with 
ECL (Perkin Elmer Western Lighting Chemilumines-
cence Reagent Plus, «Perkin Elmer», USA). RUNX2-
specific mouse monoclonal antibodies were a generous 
gift of Dr. Yoshiaki Ito (Institute for Molecular and
Cellular Biology, Singapore). CDK2 rabbit polyclonal
antibodies (SC-163) were purchased from Santa Cruz
Biotechnology, Santa Cruz, USA.
Quantitative real-time reverse transcriptase PCR
(qRT-PCR) analysis. qRT-PCR was performed to vali-
date changes for the sub-set of Runx2 responsive ge-
nes. Specific qPCR primers were designed using Pri-
mer 3 software. Total RNA for qRT-PCR assays was
isolated as described, subjected to DNaseI digestion
and purified using an RNA purification kit («Zy-
mogen», USA). Aliquots of RNA (1 µg) were used for
reverse transcription (First strand cDNA synthesis kit,
«Invitrogen», USA) with random hexamer primers.
Quantitative PCR was performed with Power SYBR
Green PCR Master Mix («Applied Biosystems», USA)
using an automated system (Applied Biosystems 7300
Real Time PCR System) with 0.5 pmoles/µl of the spe-
cific gene primers.
Results and discussion. Functional clustering of
Runx2 responsive genes in osteoprogenitors. To inves-
tigate Runx2 involvement in the programming of os-
teoprogenitors, we used the model system of early
mouse calvaria osteoprogenitors with Runx2 null back- 
ground. These cells are blocked at the very early stage
of osteogenic lineage because of the absence of Runx2
gene; although they deposit collagen into extracel-
lular matrix, they do not express other phenotypic mar-
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kers and are not able to differentiate and mineralize in
osteogenic media (ascorbic acid and beta-glycero-
phosphate). After cells reconstitution with exogenous-
ly expressed Runx2 protein the block is released and
cells progress along osteoblatic lineage, differentiate to 
normal osteoblasts and mineralize in osteogenic media.
To assess the global changes in gene expression du- 
ring the osteoblatic lineage the genome-wide Affy-
metrix expression profiling was performed with the
investigated cells reconstituted  with either wild type
(WT) Runx2 protein or with its C-terminally truncated
deletion mutant (Runx2-∆C), which is non-functional
because of the absence of transactivation and repres-
sion domains (Fig. 1).
Data analysis after Runx2 WT and  Runx2-∆C
introduction revealed total 1828 probe-sets and 1438
up- and down-regulated genes (with more than 1.4 fold
changes, p < 0.05) (Table). Functional clustering of
these genes has shown that several clusters of func-
tionally related genes are responsive to Runx2 in-
troduction, and include the genes related to cell signa-
ling pathways, general metabolism, transport, cell cyc-
le and osteoblast phenotype. The changes in expression 
of selected subset of 180 genes were validated by quan- 
titative PCR (qPCR) analysis and revealed a significant 
consistency with the data obtained by microarray. 
Early osteoblast phenotypic genes are induced by
Runx2 in osteoblasts progenitors. As we expected, the
functional clustering of results has shown that the
genes of the early/middle osteoblast differentiation
encoding Osteocalcin, Osteopontin, some collagens
and Matrix metalloproteinases, were robustly induced
by Runx2 within 1 day after Runx2 re-introduction
(Fig. 2). The genes characteristic for the late diffe-
rentiation stage encoding Bone sialoprotein, Alkaline
phosphatase have not revealed detectable expression
(data not shown).
Matrix metalloproteinases Mmp9, Mmp13 and so-
me other collagen matrix processing enzymes (i. e.
Loxl2, Loxl3, Tissue Inhibitors of Matrix Metallopro-
teinases Timp1 and Timp3) were robustly induced by
Runx2, while others (i. e. Timp2) were inhibited. Con-
sistently, a sub-set of bone-related Runx2 responsive
genes like secreted phosphoprotein (Spp1, Osteopon-
tin), Bone gamma-carboxyglutamate (Bglap1, Osteo-
calcin) were also up-regulated. Some genes in the list
encode other master fate-determining transcription fac- 
tor in osteoblasts acting up- and downstream of Runx2
protein (e. g. Core binding factor beta (Cbfb), Sp7 or
Osterix).
Runx2 programs bone-related signaling network in 
osteoprogenitor cell. Along with the cluster of osteo-
275
BONE-SPECIFIC MASTER TRANSCRIPTION FACTOR RUNX2
A
Runx2-WT                                                  Runx2-∆361                                                    GFP-EV
C
Ru
nx
2-W
T
Ru
nx
2-
∆3
61
GF
P-
sig
na
l
No
vir
us
RNA:                                           
Runx2
Gapdh
B
Protein:                                                        
No
vir
us
Ru
nx
2-W
T
Ru
nx
2-
∆3
61
GF
P-
sig
na
l
Runx2
Cdk2
Fig. 1. Runx2 overex-
pression in Runx2 null
mouse calvaria cells: A – 
Runx2 wild type (WT),
C-terminal truncated
Runx2 mutant (aa 1–
361, ∆C) or GFP control
protein were expressed
via adenoviral infections 
in Runx2 null cells (åqu- 
al infection efficiency
was determined by GFP
signal); B, C – åxoge-
nous Runx2 protein and
RNA expression levels
were detected by Wes-
tern blot and RT-PCR
respectively
blast phenotypic gene markers, several other big clus-
ters of interrelated genes were responsive to Runx2.
The biggest of these clusters includes genes coding for
cell signaling pathways, namely transmembrane recep- 
tors, extra- and intracellular modulators of their activi-
ty, cytoplasmic secondary messengers and the nuclear
effectors. Among the most affected signaling pathways 
we identified all known critical signaling components
in osteogenesis, including FGF, BMP/TGFbeta, Wnt
and small G-proteins coupled signaling (e. g. PTH/
PTHrP, non-genomic steroid receptor Gpr30, cAMP
signaling, growth factors FGF and EGF signaling).
We further arranged a sub-cluster of Runx2 res-
ponsive genes related to G-protein coupled signaling in 
osteoblasts (Fig. 3). A bunch of G-protein coupled re-
ceptors and their interacting G-proteins are up- and
down-regulated in osteoprogenitors. Some of these ge-
nes are known to play a role in osteoblastic cells (e. g.
non-genomic Estrogen receptor Gpr30, Gper), while
the function of other G-proteins coupled receptors (e. g. 
Gpr54, Gpr23) in bone has to be determined. The four
of the Small Regulators of G-proteins (Rgss) are rep-
ressed by Runx2: Rgs2, 4, 5 and 16 (Fig. 3). Notably,
Rgs2 and Rgs4 are known as molecular switches
directing the signal along different ways from PTH/
PTHrP receptor [7, 8], the critical modulator of
osteoblastic differentiation, growth and function [9].
Further investigation is needed to determine if these
changes affect signaling pathway from PTH/PTHrP
receptor during differentiation.
The second sub-cluster includes the extracellular
matrix/proteoglycan genes known as the regulators of
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Functional cluster Probe-sets
Genes
Total Up-regulation Down-regulation
Total change 1828 1438 660 778
Not annotated yet 211 198 75 123
Genes with unknown function 234 191 94 97
Miscellaneous 147 121 47 74
Signaling network 268 192 75 117
Biosynthesis/metabolism 135 102 60 42
Cytokines/Inflammatory response 121 87 38 49
Growth/Cell cycle 93 70 41 29
Cytoskeleton/transport/proteins sorting 90 68 27 41
Proteasome degradation 70 57 21 36
Channels/transporters 77 56 22 34
Bone phenotypic genes 61 45 22 23
RNA binding/splicing/metabolism 51 41 27 14
Myogenic phenotype 46 36 21 15
Adhesion/Migration/communications 42 32 3 29
Steroids biosynthesis/metabolism 37 31 16 15
Heat shock/Chaperones 47 30 25 5
Apoptosis 38 30 16 14
Function in nervous system 32 26 8 18
Translation 28 25 22 3
The number of genes up- and down-regulated by Runx2 in osteoprogenitors
FGF, Wnt and BMP signaling, critical in the bone cells
[10, 11]. Heparane sulfate proteoglycanes (Syndeca-
nes) physically interact with FGF receptors as well as
FGF ligands and regulate signaling activity depending
on the types of Heparane sulfate chains present [12].
The enzymes modifying chemical composition of
Heparane sulfate chains components along with
Proteoglycans co-repressors themselves are Runx2
responsive (Fig. 4), indicating that Runx2 plays a role
as a modulator of the whole FGF signaling system.
Runx2 modulates steroid hormones biosynthesis
and cholesterol metabolism machinery in osteoproge-
nitors. The second big cluster of genes responsive to
Runx2 includes the genes responsible for cellular me-
tabolism (Table), particularly for lipid/fatty acid, su-
gars and energy metabolism, red-ox homeostasis and
cholesterol/steroid hormones biogenesis (Fig. 5). The-
re are genes coding for the enzymes for several con-
secutive steps of cholesterol biosynthesis (Fdps, Lss,
Cyp51, Dhcr) following by Cholesterol downstream
conversion to Pregnenolone (Cyp11a1, Fdxr) are indu-
ced by Runx2. Interestingly, the genes related to bone-
catabolic glucocorticoids signaling, including Gluco-
corticoid receptors (Nr3c1, Nr2c2) and Glucocorti-
coid-induced gene (Gig1, Zfp704) are inhibited by
Runx2 expression (Fig. 5). Taken together these data
suggest that Runx2 may promote the endogenous bio-
genesis of some anabolic steroid hormones derivatives
of cholesterol in differentiating osteoblasts, while re-
pressing signaling from catabolic glucocorticoids.
We performed genome-wide screening of the genes 
that are directly or indirectly regulated by the bone
master regulatory transcription factor Runx2 at the
early stage of osteoblastic commitment. We found that
several interrelated functional gene programs are archi- 
tected by the presence of Runx2 in osteoprogenitors,
including early steps of bone matrix production, regu-
lation of osteoblastic cell cycle, general metabolism,
steroids biogenesis and the membrane/intracellular sig- 
naling network. 
Genetic alterations of osteoblast specific signaling
pathways that we have identified – FGF, PTH/PTHrP,
BMP, TGFβ and Wnt signaling, cause hereditary syn-
dromes with prominent bone abnormalities. Also, there 
are tremendous amount of accumulated evidences that
each of above-mentioned signaling pathways plays a
critical role in osteoblasts development and bone for-
mation, both in vivo and in vitro [13].
Moreover, proper hormone signaling involving all
classes of steroids is critical for bone development and
homeostasis. For example deficiency of Estrogen or
Androgen receptor leads to severe osteoporosis; defi-
ciency of Vitamin D is well known to cause Rickets,
while glucocorticoid treatment is associated with glu-
cocorticoid-induced osteoporosis.
Taken together, these results guided us to a novel
fundamental concept that the master transcriptional
regulator (i. e. Runx2) changes representation of the
total signaling network of the cell, and that such change 
may be a principal part of the fate-determining program 
to define cell identity in the environment. In other
words, due to reprogramming its signaling network,
Runx2 expressing osteoprogenitor reacts and behaves  
differently from its mother Mesenchymal stem cell in
the same bone microenvironment, retaining the osteo-
progenitor identity memory. The retention of such
memory can be realized by  chromatin remodeling (as
Runx2 is  a  part of chromatin modification complexes)
as well as by the retention of Runx2 on mitotic chromo- 
somes through progenitor cells generations.
At the same time, using bone as a model system, it
is a part of broader biological problem of understan-
ding the complete mechanism of cell specialization and 
(re)programming by master regulatory factors. Still  far 
from understanding, this question is of the critical
importance in the new and fast growing field of stem
cell-based regenerative medicine, which has tremen-
dous potential for improving both healthcare and  hu-
man wellbeing.
Í. Ì. Òåï ëþê, Â. ². Òåï ëþê 
Òðà íñêðèïö³éíèé ôàê òîð Runx2 ðå ãó ëþº ãå íå òè÷í³ 
ïðî ãðà ìè, ïî â’ÿ çàí³ ³ç ñèã íàë³íãîì ³ ìå òà áîë³çìîì 
ïî ïå ðåä íèê³â îñòå îá ëàñò³â
Ðå çþ ìå
Ìåòà.  Òðà íñêðèïö³éíèé ôàê òîð Runx2 (AML3) º âàæ ëè âèì ðå -
ãó ëÿ òî ðîì äè ôå ðåíö³àö³¿ îñòå îá ëàñò³â, íå îáõ³äíèì äëÿ ôîð -
ìó âàí íÿ ê³ñòîê. Åêñïðåñ³ÿ ãåíà Runx2 çðîñ òàº â ïðî öåñ³ äè-
ôå ðåíö³àö³¿ îñòå îá ëàñò³â ³ ïðè çâî äèòü äî àê òè âàö³¿ îñòåî-
áëàñò-ñïå öèô³÷íèõ ãåí³â, â³äïîâ³äàëü íèõ çà ïðî äó êó âàí íÿ ì³íå -
ðàëü íî ãî ìàò ðèê ñó. Ìåòà ðî áî òè ïî ëÿ ãà ëà ó âèç íà ÷åíí³
ôóíêö³¿ ãåíà Runx2 ó ïî ïå ðåä íè êàõ îñòå îá ëàñò³â, äå â³í åêñïðå -
ñóºòüñÿ íà äî ñèòü íèç ü êî ìó ð³âí³. Ìå òî äè. Ìè äîñë³äèëè
ôóíêö³þ ãåíà Runx2 íà ðàíí³õ ñòàä³ÿõ ðîç âèò êó îñòå îá ëàñò³â
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çà äî ïî ìî ãîþ ìî äåëü íî¿ ñèñ òå ìè Runx2-íî êà óò íèõ êë³òèí
ñêàëüï³â ìè øåé, ÿêèì ââî äè ëè ãåí Runx2. Ðå çóëü òà òè. Ïðè
äîñë³äæåíí³ åêñïðåñ³¿ ãå íî ìó çà äî ïî ìî ãîþ Affymetrix ÷èï³â âè -
ÿâ ëå íî, ùî ðàç îì ³ç ³íäóêö³ºþ ôå íî òè ïî âèõ ìàð êåð³â â³äêëà äàí -
íÿ çîâí³øíüîêë³òè íî ãî ì³íå ðàëü íî ãî ìàò ðèê ñó ãåí Runx2
ðå ãó ëþº äåê³ëüêà ãå íå òè÷ íèõ ïðî ãðàì, ïî â’ÿ çà íèõ ³ç ñèã íà-
ë³íãîì ³ ìå òà áîë³çìîì ïî ïå ðåä íèê³â îñòå îá ëàñò³â. Çîê ðå ìà,
Runx2 ðå ãó ëþº ãåíè ñèã íàëü íî¿ ìå ðåæ³, ç÷åï ëå íî¿ ç G-á³ëêà ìè,
ñèã íàëüí³ øëÿ õè FGF, BMP/TGF, à òà êîæ ôåð ìåí òà òèâí³ ñèñ -
òå ìè á³îñèí òå çó ³ ìå òà áîë³çìó ñòå ðî¿ äíèõ ãîð ìîí³â. Âèñ íîâ -
êè. Îòðè ìàí³ äàí³ âêà çó þòü íà òå, ùî ÷àñ òè íà ïðî ãðà ìè ñïå-
ö³àë³çàö³¿, ÿêó âè êî íóº êëþ ÷î âèé òðàíñ êðèïö³éíèé ôàê òîð,
ñêëà äàºòüñÿ ç ïðî ãðà ìó âàí íÿ ñèã íàëü íèõ øëÿõ³â òà ìå òà -
áîë³çìó êë³òèíè, äîç âî ëÿ þ ÷è ðàí íüîñ ïåö³àë³çî âàí³é êë³òèí³ ðå -
à ãó âà òè òà ôóíêö³îíó âà òè ïåâ íèì ÷è íîì ó ì³êðî ñå ðå äî âèù³.
Êëþ ÷îâ³ ñëî âà: ïî ïå ðåä íèêè îñòå îá ëàñò³â, Runx2, ñèã -
íàë³íã.
Í. Ì. Òåï ëþê, Â. È. Òåï ëþê
Òðà íñêðèï öè îí íûé ôàê òîð Runx2 ðå ãó ëè ðó åò 
ãå íå òè ÷åñ êèå ïðî ãðàì ìû, ñâÿ çàí íûå ñ ñèã íà ëèí ãîì è 
ìå òà áî ëèç ìîì ïðåä øåñ òâåí íè êîâ îñòå îá ëàñòîâ
Ðå çþ ìå
Öåëü. Òðà íñêðèï öè îí íûé ôàê òîð Runx2 (AML3) ÿâ ëÿ åò ñÿ êëþ -
÷å âûì ðå ãó ëÿ òî ðîì äèô ôå ðåí öè à öèè îñòå îá ëàñ òîâ, íå îá õî äè -
ìûì äëÿ ôîð ìè ðî âà íèÿ êîñ òåé. Ýêñïðå ñèÿ ãåíà Runx2 ïîâû-
øà åò ñÿ â ïðî öåñ ñå äèô ôå ðåí öè à öèè îñòå îá ëàñ òîâ, ãäå îí àê -
òè âè ðó åò îñòå îá ëàñò-ñïå öè ôè ÷åñ êèå ãåíû, íå îá õî äè ìûå äëÿ
ïðîäóê öèè ìè íå ðàëü íî ãî ìàò ðèê ñà. Öåëü ðà áî òû ñî ñòî ÿ ëà â
îïðå äå ëå íèè ôóíê öèè ãåíà Runx2  â ðàí íèõ ïðåä øåñ òâåí íè êàõ
îñòå îá ëàñ òîâ, ãäå îí ýêñ ïðåñ ñè ðó åò ñÿ íà äîñ òà òî÷ íî íèç êîì
óðîâ íå. Ìå òî äû. Ìû èñ ñëå äî âà ëè, êàê Runx2 ôóíê öè î íè ðó åò
íà ðàí íèõ ñòà äè ÿõ ñïå öè à ëè çà öèè îñòå îá ëàñ òîâ ñ ïî ìîùüþ
ìî äåëü íîé ñèñ òå ìû âíåä ðå íèÿ Runx2 â Runx2-íî êà óò íûå êëåò -
êè ñêàëü ïà ìûøè. Ðå çóëü òà òû.  Ïðè èç ó÷å íèè ýêñ ïðå ñèè ãå íî -
ìà ñ ïî ìîùüþ Affymetrix ÷è ïîâ îá íà ðó æå íî, ÷òî âìåñ òå ñ èí-
äóê öè åé ôå íî òè ïè÷ íûõ ìàð êå ðîâ, îò âå ÷à þ ùèõ çà ïðî äóê öèþ
âíåê ëå òî÷ íî ãî ìàò ðèê ñà, Runx2 ðå ãó ëè ðó åò íå ñêîëü êî ãå íå òè -
÷åñ êèõ ïðî ãðàìì, ñâÿ çàí íûõ ñ ñèã íà ëèí ãîì è ìå òà áî ëèç ìîì
îñòå îá ëàñ òîâ. Â ÷àñ òíîñ òè, Runx2 ðå ãó ëè ðó åò ãåíû ñèã íàëü -
íîé ñåòè, ñöåï ëåí íîé ñ G-áåë êà ìè, ñèã íàëü íûõ ïó òåé FGF,
BMP/TGF, à òàê æå ñèñ òå ìû áè î ñèí òå çà è ìå òà áî ëèç ìà ñòå -
ðî èä íûõ ãîð ìî íîâ. Âû âî äû. Ïî ëó ÷åí íûå äàí íûå óêà çû âà þò íà
òî, ÷òî ïðî ãðàì ìà ñïå öè à ëè çà öèè, âû ïîë íÿ å ìàÿ êëþ ÷å âûì
òðàíñ êðèï öè îí íûì ôàê òî ðîì, âêëþ ÷à åò ïðî ãðàì ìè ðî âà íèå
ñèã íàëü íûõ ïó òåé è ìå òà áî ëèç ìà êëåò êè, ïî çâî ëÿÿ ðàí íå äèô -
ôå ðåí öè ðî âàí íîé êëåò êå âåñ òè ñåáÿ îïðå äå ëåí íûì îá ðà çîì â
èäåí òè÷ íîé ìèê ðîñ ðå äå.
Êëþ ÷å âûå ñëî âà: ïðåä øåñ òâåí íè êè îñòå îá ëàñòîâ, Runx2,
ñèã íàëèíã.
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